Rare diseases
Investigational molecules
Locations
353 conditions with trials, the busiest first
844 trials across Europe, recruiting first
Study of amlitelimab injection compared to placebo for adults with severe alopecia areata (hair loss)
BulgariaStudy on the Safety and Effects of Sebetralstat for Children Aged 2-11 with Hereditary Angioedema Type I or II
FranceStudy on Remibrutinib for Adults with Chronic Inducible Urticaria Uncontrolled by H1-Antihistamines
FranceStudy on Anifrolumab for Adults with Chronic or Subacute Cutaneous Lupus Erythematosus Unresponsive to Antimalarial Therapy
AustriaStudy on the Effects of Belimumab and Rituximab for Patients with Severe Systemic Lupus Erythematosus
The NetherlandsStudy on the Effectiveness and Safety of Sonelokimab for Adults with Moderate to Severe Hidradenitis Suppurativa
AustriaStudy on Tralokinumab for Children Aged 6-11 with Moderate-to-Severe Atopic Dermatitis
CzechiaStudy on Baricitinib for Treating New-Onset Juvenile Dermatomyositis in Children
FranceStudy on Basimglurant for Children, Adolescents, and Young Adults with Tuberous Sclerosis Complex-Related Seizures
ItalyStudy of deucravacitinib in adults with plaque psoriasis: Effects on immune system cells
GermanyStudy on Ustekinumab and Drug Combination for Patients with Severe, Resistant Inflammatory Disease
FranceStudy on the Safety and Effects of Tolinapant in Patients with Advanced Solid Tumors and Lymphomas
ItalyThe therapies tested most often in Skin and subcutaneous tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
